← Back to Search

Supervised exercise therapy for Diastasis Recti

N/A
Waitlist Available
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks post intervention, 9 months post intervention
Awards & highlights

Study Summary

The purpose of this study is to determine the effect of two different physiotherapeutic interventions (exercise therapy and/or abdominal binding) on the signs and symptoms of diastasis recti in post-partum women.

Eligible Conditions
  • Diastasis Recti

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks post intervention, 9 months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks post intervention, 9 months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Inter-Rectus Distance
Secondary outcome measures
Change in Abdominal Strength and Endurance
Change in Body image
Change in Lumbopelvic dysfunction
+3 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Supervised exercise therapyExperimental Treatment1 Intervention
Participants will receive 12 sessions with a physiotherapist where they will receive instructions on body mechanics, and be given a progressive abdominal exercise program
Group II: Exercise therapy and Abdominal BindingExperimental Treatment2 Interventions
Participants will attend 12 sessions with a physiotherapist, and receive an abdominal binder
Group III: Abdominal bindingExperimental Treatment1 Intervention
Participants will be fitted for an abdominal binder and asked to wear it for a period of 12 weeks.
Group IV: ControlActive Control1 Intervention
Participants will not receive an intervention during the study period

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
369 Previous Clinical Trials
121,846 Total Patients Enrolled
University of TorontoOTHER
698 Previous Clinical Trials
1,020,570 Total Patients Enrolled
McLean Linda, PhDStudy DirectorQueen's University
~3 spots leftby Jun 2025